Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada.
COVID-19 vaccine
Gender diverse populations
HIV
Intention to vaccinate
Social determinants of health
Vaccine hesitancy
Women
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
accepted:
31
12
2021
pubmed:
13
1
2022
medline:
7
6
2022
entrez:
12
1
2022
Statut:
ppublish
Résumé
COVID-19 vaccination is recommended for people living with HIV (PLWH), among whom social inequities and co-morbidities may drive risks of COVID-19 infection and outcome severity. Among a provincial (British Columbia) sample, we determined the prevalence of COVID-19 vaccine intention by HIV status and assessed socio-demographic, vaccine hesitancy, and psychological predictors of vaccine intention. Individuals (25-69 years) recruited from province-wide research cohorts and the general public completed an online survey examining COVID-19 impacts (August/2020-March/2021). In an analysis restricted to women and gender diverse participants (n = 5588), we compared intention to receive a recommended COVID-19 vaccine (Very likely/Likely vs Neutral/Unlikely/Very Unlikely) by self-reported HIV status. Logistic regression models assessed the independent effect of HIV status and other factors on COVID-19 vaccine intention. Of 5588 participants, 69 (1.2%) were living with HIV, of whom 79.7% were on antiretroviral therapy. In bivariate analyses, intention to vaccinate was significantly lower among PLWH compared to participants not living with HIV (65.2% vs 79.6%; OR 0.44; 95%CI 0.32-0.60). However, this association was not statistically significant after adjustment for ethnicity, income, education, and essential worker status (aOR 0.85; 95%CI 0.48-1.55). Among PLWH, those with greater vaccine confidence, positive attitudes towards the COVID-19 vaccine, and more strongly influenced by direct and indirect social norms to vaccinate had significantly higher odds of vaccine intention. Tailored messaging is needed to build vaccine confidence, address questions about vaccine benefits, and support informed vaccination decision-making to promote COVID-19 vaccine uptake among women and gender diverse people living with HIV.
Identifiants
pubmed: 35020094
doi: 10.1007/s10461-022-03577-w
pii: 10.1007/s10461-022-03577-w
pmc: PMC8753016
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2242-2255Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Government of Canada. COVID-19 daily epidemiology update 2021 [Available from: https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html#a7 . Accessed 10 July 2021.
Sundaram ME, Calzavara A, Mishra S, Kustra R, Chan AK, Hamilton MA, et al. Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study. CMAJ. 2021;193(20):E723–34.
doi: 10.1503/cmaj.202608
McKenzie K. Socio-demographic data collection and equity in covid-19 in Toronto. EClinicalMedicine. 2021;34:100812.
doi: 10.1016/j.eclinm.2021.100812
Morgan R, Baker P, Griffith DM, Klein SL, Logie CH, Mwiine AA, et al. Beyond a zero-sum game: how does the impact of COVID-19 vary by gender? Front Sociol. 2021. https://doi.org/10.3389/fsoc.2021.650729 .
doi: 10.3389/fsoc.2021.650729
pubmed: 34212026
pmcid: 8239350
Centers for Disease Control and Prevention (CDC). What to know about HIV and COVID-19 2021. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/hiv.html . Accessed 1 March 2021.
Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8(1):e24–32.
doi: 10.1016/S2352-3018(20)30305-2
Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR. Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study. AIDS. 2020;34(13):F3–8.
doi: 10.1097/QAD.0000000000002666
Miyashita H, Kuno T. Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City. HIV Med. 2021;22(1):e1–2.
doi: 10.1111/hiv.12920
Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021;16(1):63–73.
doi: 10.1097/COH.0000000000000659
Collins LF. Persons with human immunodeficiency virus and the coronavirus disease 2019 pandemic: a viral synergy of biology and sociology. Clin Infect Dis. 2020;73:e2106.
doi: 10.1093/cid/ciaa1715
National Advisory Committee on Immunization (NACI). Recommendations on the use of COVID-19 vaccines [Internet]. 2021. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html . Accessed 1 March 2021.
Government of Canada. Canada’s COVID-19 Immunization Plan: Saving Lives and Livelihoods [Internet]. 2020. https://www.canada.ca/content/dam/phac-aspc/documents/services/diseases/2019-novel-coronavirus-infection/canadas-reponse/canadas-covid-19-immunization-plan-en.pdf . Accessed 1 March 2021.
Pebody R. Have COVID-19 vaccines been tested in people with HIV? 2021. https://www.aidsmap.com/about-hiv/have-covid-19-vaccines-been-tested-people-hiv . Accessed 1 May 2021.
Burns F. HIV and COVID-19 vaccines. International Workshop on HIV and Women; Virtual. https://academicmedicaleducation.com/hiv-women-2021 . Accessed 26 April 2021.
BC Centre for Excellence in HIV/AIDS (BCCfE). CDET Committee Statement Update on the use of COVID-19 vaccines in persons living with HIV May 7 2021. http://bccfe.ca/sites/default/files/uploads/publications/centredocs/covid-19_vaccine_cdet_update_final_5_pm_2021_may_9th_.pdf . Accessed 1 June 2021.
MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.
doi: 10.1016/j.vaccine.2015.04.036
World Health Organization (WHO). Report of the SAGE working group on vaccine hesitancy (October 2014). 2014. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf . Accessed 1 March 2021.
Bogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200–7.
doi: 10.1097/QAI.0000000000002570
Grumbach K, Judson T, Desai M, Jain V, Lindan C, Doernberg SB, et al. Association of race/ethnicity with likeliness of COVID-19 vaccine uptake among health workers and the general population in the San Francisco Bay Area. JAMA Intern Med. 2021;181(7):1008–11.
doi: 10.1001/jamainternmed.2021.1445
Ogilvie GS, Gordon S, Smith LW, Albert A, Racey CS, Booth A, et al. Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada. BMC Public Health. 2021;21(1):1017.
doi: 10.1186/s12889-021-11098-9
Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 vaccine hesitancy among French people living with HIV. Vaccines. 2021;9(4):302.
doi: 10.3390/vaccines9040302
Bourgeois AC, Edmunds M, Awan A, Jonah L, Varsaneux O, Siu W. HIV in Canada—Surveillance Report, 2016. Can Commun Dis Rep. 2017;43(12):248–56.
doi: 10.14745/ccdr.v43i12a01
Shokoohi M, Bauer GR, Kaida A, Lacombe-Duncan A, Kazemi M, Gagnier B, et al. Social determinants of health and self-rated health status: a comparison between women with HIV and women without HIV from the general population in Canada. PLoS ONE. 2019;14(3):e0213901.
doi: 10.1371/journal.pone.0213901
Donaldson MA, Campbell AR, Albert AY, Borhani M, Nesbitt A, Côté HCF, et al. Comorbidity and polypharmacy among women living with HIV in British Columbia. AIDS. 2019;33(15):2317–26.
doi: 10.1097/QAD.0000000000002353
Kendall CE, Wong J, Taljaard M, Glazier RH, Hogg W, Younger J, et al. A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Public Health. 2014;14(1):161.
doi: 10.1186/1471-2458-14-161
Lourenço L, Colley G, Nosyk B, Shopin D, Montaner JS, Lima VD. High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada. PLoS ONE. 2014;9(12):e115277.
doi: 10.1371/journal.pone.0115277
Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, et al. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36(5):660–7.
doi: 10.1016/j.vaccine.2017.12.043
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.
doi: 10.1016/0749-5978(91)90020-T
Women’s Health Research Institute (WHRI). RESPPONSE: Rapid Evidence Study of a Provincial Population Based COhort for GeNder and SEx. 2020. https://whri.org/covid-19-respponse-study/ . Accessed 1 Feb 2021.
Loutfy M, de Pokomandy A, Kennedy VL, Carter A, O’Brien N, Proulx-Boucher K, et al. Cohort profile: The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS). PLoS ONE. 2017;12(9):e0184708.
doi: 10.1371/journal.pone.0184708
Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d’Arminio Monforte A, et al. Caring for women living with HIV: gaps in the evidence. J Int AIDS Soc. 2013;16(1):18509.
doi: 10.7448/IAS.16.1.18509
Hankins C. Gender, sex, and HIV: how well are we addressing the imbalance? Curr Opin HIV AIDS. 2008;3(4):514–20.
doi: 10.1097/COH.0b013e32830136b4
Webster K, Carter A, Proulx-Boucher K, Dubuc D, Nicholson V, Beaver K, et al. Strategies for recruiting women living with human immunodeficiency virus in community-based research: lessons from Canada. Prog Community Health Partnersh. 2018;12(1):21–34.
doi: 10.1353/cpr.2018.0003
Canadian Institutes of Health Research (CIHR). Strategy for patient-oriented research—patient engagement framework 2019. https://cihr-irsc.gc.ca/e/48413.html . Accessed 1 March 2021.
Kaida A, Carter A, Nicholson V, Lemay J, O’Brien N, Greene S, et al. Hiring, training, and supporting Peer Research Associates: operationalizing community-based research principles within epidemiological studies by, wtih, and for women living with HIV. Harm Reduct J. 2019;16:8. https://doi.org/10.1186/s12954-019-0309-3 .
doi: 10.1186/s12954-019-0309-3
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
doi: 10.1016/j.jbi.2008.08.010
Statistics Canada. Ethnic Origin Reference Guide, Census of Population, 2016. 2017. https://www12.statcan.gc.ca/census-recensement/2016/ref/guides/008/98-500-x2016008-eng.cfm . Accessed 1 July 2020.
Government of British Columbia. COVID-19 List of Essential Services 2020. https://www2.gov.bc.ca/assets/gov/family-and-social-supports/covid-19/list_of_essential_services.pdf . Accessed 1 July 2020.
R Core Team. The R Project for Statistical Computing v.4.0.2. 2020. https://www.r-project.org/ . Accessed 16 Nov 2020.
Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–7.
doi: 10.1007/s10900-020-00958-x
Frater J, Ewer KJ, Ogbe A, Pace M, Adele S, Adland E, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021;8:e474.
doi: 10.1016/S2352-3018(21)00103-X
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273–82.
doi: 10.1056/NEJMoa2104983
Patterson S, Nicholson V, Milloy MJ, Ogilvie G, Hogg RS, Carter A, et al. Awareness and understanding of HIV non-disclosure case law and the role of healthcare providers in discussions about the criminalization of HIV non-disclosure among women living with HIV in Canada. AIDS Behav. 2020;24(1):95–113.
doi: 10.1007/s10461-019-02463-2
Kaida A, Carter A, Nicholson V, Lemay J, O’Brien N, Greene S, et al. Hiring, training, and supporting Peer Research Associates: operationalizing community-based research principles within epidemiological studies by, with, and for women living with HIV. Harm Reduct J. 2019;16(1):47.
doi: 10.1186/s12954-019-0309-3
Loutfy M, Greene S, Kennedy VL, Lewis J, Thomas-Pavanel J, Conway T, et al. Establishing the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS): operationalizing community-based research in a large national quantitative study. BMC Med Res Methodol. 2016;16(1):101.
doi: 10.1186/s12874-016-0190-7
Government of British Columbia. COVID-19 Immunization Plan. 2020. https://www2.gov.bc.ca//gov/content/covid-19/vaccine/plan . Accessed 1 June 2021.
Government of British Columbia. British Columbia COVID-19 dashboard. 2021. https://experience.arcgis.com/experience/a6f23959a8b14bfa989e3cda29297ded . Accessed 8 July 2021.
BC Centre for Disease Control (BCCDC). HIV in British Columbia: Annual Surveillance Report 2017. 2019. http://www.bccdc.ca/health-professionals/data-reports/hiv-aids-reports . Accessed 1 June 2021.